Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study, international chronic fatigue syndrome study group. Ann Intern Med 1994, 121:953-959.
Lakhan S.E., Kirchgessner A. Gut inflammation in chronic fatigue syndrome. Nutr Metab 2010, 7:79.
Aaron L.A., Burke M.M., Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 2000, 160(2):221-227.
Scully P., McKernan D.P., Keohane J., Groeger D., Shanahan F., Dinan T.G., et al. Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol 2010, 105(10):2235-2243.
Maes M., Twisk F.N., Kubera M., Ringel K., Leunis J.C., Geffard M. Increased IgA responses to the LPS of commensal bacteria is associated with inflammation and activation of cell-mediated immunity in chronic fatigue syndrome. JAffect Disord 2012, 136(3):909-917.
O'Hara A.M., Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006, 7(7):688-693.
Kosiewicz M.M., Zirnheld A.L., Alard P. Gut microbiota, immunity, and disease: a complex relationship. Front Microbiol 2011, 2:180.
Hawrelak J.A., Myers S.P. The causes of intestinal dysbiosis: a review. Altern Med Rev 2004, 9(2):180-197.
Lyte M., Varcoe J.J., Bailey M.T. Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation. Physiol Behav 1998, 65(1):63-68.
Cryan J.F., O'Mahony S.M. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil 2011, 23(3):187-192.
Logan A.C., Venket Rao A., Irani D. Chronic fatigue syndrome: lactic acid bacteria may be of therapeutic value. Med Hypothesis 2003, 60(6):915-923.
Sheedy J.R., Wettenhall R.E., Scanlon D., Gooley P.R., Lewis D.P., McGregor N., et al. Increased D-lactic acid intestinal bacteria in patients with chronic fatigue syndrome. InVivo 2009, 23(4):621-628.
Rao A.V., Bested A.C., Beaulne T.M., Katzman M.A., Ioro C., Berardi J.M., et al. Arandomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog 2009, 1(1):6.
Sullivan A., Nord C.E., Evengard B. Effect of supplement with lactic-acid producing bacteria on fatigue and physical activity in patients with chronic fatigue syndrome. Nutr J 2009, 8:4.
Brugère J.F., Mihajlovski A., Missaoui M., Peyret P. Tools for stools: the challenge of assessing human intestinal microbiota using molecular diagnostics. Expert Rev Mol Diagn 2009, 9(4):353-365.
Serino M., Chabo C., Burcelin R. Intestinal microbiOMICS to define health and disease in human and mice. Curr Pharm Biotechnol 2012, 13(5):746-758.
Zhang H., DiBaise J.K., Zuccolo A. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A 2009, 106(7):2365-2370.
Finegold S.M., Dowd S.E., Gontcharova V., Liu C., Henley K.E., Wolcott R.D., et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 2010, 16(4):444-453.
Andersson A.F., Lindberg M., Jakobsson H., Bäckhed F., Nyren P., Engstrand L. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One 2008, 3(7):e2836.
Schloss P.D., Westcott S.L., Ryabin T., Hall J.R., Hartmann M., Hollister E.B., et al. Introducing Mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 2009, 75(23):7537-7541.
Everitt B. Graphical techniques for multivariate data. Heineman Educational Books; London: 1st ed.
Coomans D., de Vel O. Pattern analysis and classification. Chemometrics in environmental chemistry - statistical methods 1995, vol. 2(pt G):278-324. Springer-Verlag, Berlin. J. Einax (Ed.).
Coomans D., Broeckaert I. Potential pattern recognition in chemical and medical decision making. Chemometrics series 1986, Research Studies Press, Wiley and Sons Ltd., Herts, England. D. Bowden (Ed.).
Benson A.K., Kelly S.A., Legge R., Ma F., Low S.J., Kim J. Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc Natl Acad Sci U S A 2010, 107(44):18933-18938.
Brown K., DeCoffe D., Molcan E., Gibson D.L. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients 2012, 4:1095-1119.
Rajilic-Stojanovic M., Smidt H., de Vos W.M. Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol 2007, 9(9):2125-2136.
De Filippo C., Cavalieri D., Di Paola M., Ramazzotti M., Poulet J.B., Massard S., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 2010, 107(33):14691-14696.
Abreu M.T., Fukata M., Arditi M. TLR signaling in the gut in health and disease. JImmunol 2005, 174(8):4453-4460.
Louis P., Flynt H.J. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 2009, 294(1):1-8.
Morio F., Jean-Pierre H., Dubreuil L., Jumas-Bilak E., Calvet L., Mercier G., et al. Antimicrobial susceptibilities and clinical sources of Dialister species. Antimicrobial Agents Chemother 2007, 51(12):4498-4501.
Joossens M., Huys G., Cnockaert M., De Preter V., Verbeke K., Rutgeerts P., et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2011, 60(5):631-637.
Saulnier D.M., Riehle K., Mistretta T.A., Diaz M.A., Mandal D., Raza S., et al. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 2011, 141(15):1782-1791.
Rautio M., Eerola E., Vaisanen-Tunkelrott M.L., Molitoris D., Lawson P., Collins M.D., et al. Reclassification of Bacteroides putredinis in a new genus Alistipes gen. nov., as Alistipes putredinis comb. nov., and description of Alistipes finegoldii sp. nov., from human sources. Syst Appl Microbiol 2003, 26(2):182-188.
Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D.R., et al. Enterotypes of the gut microbiome. Nature 2011, 473:174-180.
Woting A., Clavel T., Loh G., Blaut M. Bacterial transformation of dietary lignans in gnotobiotic rats. FEMS Microbiol Ecol 2010, 72(3):507-514.
Mabrok H.B., Klopfleisch R., Ghanem K.Z., Clavel T., Blaut M., Loh G. Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer. Carcinogenesis 2012, 33(1):203-208.
Minamida K., Ota K., Nishimukai M., Tanaka M., Abe A., Sone T., et al. Asaccharobacter celatus gen. nov., sp. nov., isolated from rat caecum. Int J Syst Evol Microbiol 2008, 58(pt5):1238-1240.
Thawornkuno C., Tanaka M., Sone T., Asano K. Biotransformation of daidzein to equol by crude enzyme from Asaccharobacter celatus AHU1763 required an anaerobic environment. Biosci Biotechnol Biochem 2009, 73(6):1435-1438.
Gräns H., Nilsson M., Dahlman-Wright K., Evengard B., et al. Reduced levels of oestrogen receptor β mRNA in Swedish patients with chronic fatigue syndrome. JClin Pathol 2007, 60:195-198.
Veldman J., Van Houdenhove B., Verguts J. Chronic fatigue syndrome: a hormonal origin? A rare case of dysmenorrheal membranacea. Arch Gynecol Obstet 2009, 279(5):717-720.
Mueller M., Hobiger S., Jungbauer A. Red clover extract: a source for substances that activate peroxisome proliferator-activated receptor alpha and ameliorate the cytokine secretion profile of lipopolysaccharide-stimulated macrophages. Menopause 2010, 17(2):379-387.
Blay M., Espinal A.E., Delgado M.A., Baiges I., Bladé C., Arola L., et al. Isoflavone effect on gene expression profile and biomarkers of inflammation. JPharm Biomed Anal 2010, 51(2):382-390.
Lechner D., Cross H.S. Phytoestrogens and 17beta-estradiol influence vitamin D metabolism and receptor expression - relevance for colon cancer prevention. Recent Results Cancer Res 2003, 164:379-391.
Lim W.C., Hanauer S.B., Li Y.C. Mechanisms of disease: vitamin D and inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol 2005, 2(7):308-315.
Cross H.S., Nittke T., Kallay E. Colonic vitamin D metabolism: implications for the pathogenesis of inflammatory bowel disease and colorectal cancer. Mol Cell Endocrinol 2011, 347(1-2):70-79.
Jeffery L.E., Burke F., Mura M., Zheng Y., Qureshi O.S., Hewison M., et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. JImmunol 2009, 183(9):5458-5467.
Sun J. Vitamin D and mucosal immune function. Curr Opin Gastroenterol 2010, 26(6):591-595.
Hoeck A.D., Pall M.L. Will vitamin D supplementation ameliorate diseases characterized by chronic inflammation and fatigue?. Med Hypotheses 2011, 76(2):208-213.
Momozawa Y., Deffontaine V., Louis E., Medrano J.F. Characterization of bacteria in biopsies of colon and stools by high throughput sequencing of the V2 region of bacterial 16S rRNA gene in human. PLoS One 2011, 6(2):e16952.
Chia J.K., Chia A.Y. Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach. JClin Pathol 2008, 61(1):43-48.
Frémont M., Metzger K., Rady H., Hulstaert J., De Meirleir K. Detection of herpesviruses and parvovirus B19 in gastric and intestinal mucosa of chronic fatigue syndrome patients. InVivo 2009, 23(2):209-213.
